Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665569 | SCV000789715 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2017-02-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001310747 | SCV001500665 | likely pathogenic | not provided | 2020-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000665569 | SCV002187265 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2022-09-19 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 23 of the CAPN3 gene. It does not directly change the encoded amino acid sequence of the CAPN3 protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 16141003, 17702496). ClinVar contains an entry for this variant (Variation ID: 550740). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Medical Molecular Genetics Department, |
RCV000665569 | SCV005397142 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-08-11 | criteria provided, single submitter | clinical testing | By applying ACMG guidelines: According to insilico studies, the variant is classified as deleterious (PP3),our study patient’s clinical phenotype is typically correlated to the disease (PP4), it showed an extremely low frequency in gnomAD population databases (PS4) Reputable source recently reports variant as pathogenic , but the evidence is not available to the laboratory to perform an independent evaluation (PP5) so according to ACMG guidlines it is classified as likely pathogenic. |